{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:12:43Z","timestamp":1791270763460,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ijrobp.2014.06.009","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T08:47:39Z","timestamp":1407142059000},"page":"385-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Evaluation of the Lactate-to-N-Acetyl-aspartate Ratio Defined With Magnetic Resonance Spectroscopic Imaging Before Radiation Therapy as a New Predictive Marker of the Site of Relapse in Patients With Glioblastoma Multiforme"],"prefix":"10.1016","volume":"90","clinical-trial-number":[{"clinical-trial-number":"nct01507506","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Alexandra","family":"Deviers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e9akh\u00e9na","family":"Ken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Filleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Laruelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Catalaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Celsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Mogicato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Cohen-Jonathan Moyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6475-5822","authenticated-orcid":false,"given":"Anne","family":"Laprie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2014.06.009_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib2","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1259\/bjr.20120414","article-title":"Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide","volume":"86","author":"Sherriff","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0360-3016(89)90941-3","article-title":"Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma","volume":"16","author":"Wallner","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semradonc.2010.10.001","article-title":"Molecular imaging-based dose painting: A novel paradigm for radiation therapy prescription","volume":"21","author":"Bentzen","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-8-1","article-title":"Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost","volume":"8","author":"Ken","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ijrobp.2007.10.039","article-title":"Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: Predictive value for the site of postradiotherapy relapse in a prospective longitudinal study","volume":"70","author":"Laprie","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3171\/jns.2002.97.4.0794","article-title":"Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence","volume":"97","author":"McKnight","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijrobp.2007.03.019","article-title":"Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings","volume":"69","author":"Park","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2003.08.023","article-title":"3D MRSI for resected high-grade gliomas before RT: Tumor extent according to metabolic activity in relation to MRI","volume":"59","author":"Pirzkall","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11060-008-9719-x","article-title":"Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM","volume":"91","author":"Crawford","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11060-008-9685-3","article-title":"Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy","volume":"91","author":"Saraswathy","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11060-008-9625-2","article-title":"Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy","volume":"90","author":"Tabatabaei","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0360-3016(01)02769-9","article-title":"1H-MRS in\u00a0vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas","volume":"52","author":"Tarnawski","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib17","first-page":"760","article-title":"Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in\u00a0vivo","volume":"26","author":"Li","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/neuonc\/nos334","article-title":"Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging","volume":"15","author":"Li","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-008-9632-3","article-title":"Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma","volume":"90","author":"Sankar","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib20","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ejca.2013.02.033","article-title":"\u03b1v\u03b23 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I-II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma","volume":"49","author":"Ducassou","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib21","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.ijrobp.2007.02.043","article-title":"Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme","volume":"68","author":"Cohen-Jonathan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/nbm.891","article-title":"Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts","volume":"17","author":"Kreis","year":"2004","journal-title":"NMR Biomed"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib23","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00701-012-1418-x","article-title":"The relationship between Cho\/NAA and glioma metabolism: Implementation for margin delineation of cerebral gliomas","volume":"154","author":"Guo","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib24","unstructured":"Rossum, G. V. & Drake, F. L. J. The Python Language Reference Manual. (Network Theory Ltd., 2011). Available at http:\/\/www.network-theory.co.uk\/python\/language\/."},{"key":"10.1016\/j.ijrobp.2014.06.009_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijrobp.2004.09.027","article-title":"Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy","volume":"62","author":"Laprie","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib26","first-page":"6524","article-title":"Mapping extracellular pH in rat brain gliomas in\u00a0vivo by 1H magnetic resonance spectroscopic imaging: Comparison with maps of metabolites","volume":"61","author":"Garcia-Martin","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib27","first-page":"1616","article-title":"One-stop-shop tumor imaging: Buy hypoxia, get lactate free","volume":"118","author":"Manzoor","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2014.06.009_bib28","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J Clin Invest"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161403332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161403332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T01:27:47Z","timestamp":1538357267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161403332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S036030161403332X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.06.009","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Lactate-to-N-Acetyl-aspartate Ratio Defined With Magnetic Resonance Spectroscopic Imaging Before Radiation Therapy as a New Predictive Marker of the Site of Relapse in Patients With Glioblastoma Multiforme","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}